A 5‐week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long‐acting glucagon‐like peptide‐1 analogue, in patients with type 2 diabetes - Concepedia

Concepedia

Publication | Closed Access

A 5‐week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long‐acting glucagon‐like peptide‐1 analogue, in patients with type 2 diabetes

109

Citations

17

References

2011

Year

Peggy L. Barrington, Jenny Y. Chien, H. D. Hollis Showalter, Karen Schneck, Shichao Cui, Fabián Tibaldi, Bernice Ellis, Todd A. Hardy

Diabetes Obesity and Metabolism

Abstract

LY showed improvement in fasting and postprandial glycaemic parameters when administered once weekly in subjects with type 2 diabetes. The pharmacokinetics and safety profiles also support further investigation of this novel agent.

References

	Year	Citations

Page 1